Patents/Assignees

Immatics Biotechnologies GmbH

177 patents in portfolio

US11938176utility2024
Peptides and Combination of Peptides and Scaffolds for Use in Immunotherapy Against Renal Cell Carcinoma (RCC) and Other Cancers
0 cites
US11939366utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
0 cites
US11939400utility2024
Immunotherapy Against Several Tumors Including Lung Cancer
0 cites
US11939401utility2024
Immunotherapy Against Several Tumors Including Lung Cancer
0 cites
US11932678utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Esophageal Cancer and Other Cancers
0 cites
US11932689utility2024
Engineered T Cell Receptors and Immune Therapy Using the Same
0 cites
US11918607utility2024
Peptides and Combination of Peptides of Non-canonical Origin for Use in Immunotherapy Against Different Types of Cancers
0 cites
US11919940utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
0 cites
US11912748utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
0 cites
US11912749utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Ovarian Cancer and Other Cancers
0 cites
US11904003utility2024
Amidated Peptides and Their Deamidated Counterparts Displayed by HLA-A*02 for Use in Immunotherapy Against Different Types of Cancers
0 cites
US11905319utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Small Cell Lung Cancer and Other Cancers
0 cites
US11905328utility2024
Dual Specificity Polypeptide Molecule
0 cites
US11897934utility2024
Peptides and Combination of Peptides for Use in Immunotherapy Against Various Tumors
0 cites
US11897935utility2024
Peptides, Combination of Peptides as Targets and for Use in Immunotherapy Against Gallbladder Cancer and Cholangiocarcinoma and Other Cancers
0 cites
US11897936utility2024
Peptides, Combination of Peptides as Targets and for Use in Immunotherapy
0 cites
US11890333utility2024
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
0 cites
US11890334utility2024
Personalized Immunotherapy Against Several Neuronal and Brain Tumors
0 cites
US11891427utility2024
Amidated Peptides and Their Deamidated Counterparts Displayed by Non-hla-a*02 for Use in Immunotherapy Against Different Types of Cancers
0 cites
US11883462utility2024
Immunotherapy Against Several Tumors Including Gastrointestinal and Gastric Cancer
0 cites

← PreviousPage 6 of 9Next →